acyline and Insulin-Resistance

acyline has been researched along with Insulin-Resistance* in 2 studies

Trials

1 trial(s) available for acyline and Insulin-Resistance

ArticleYear
Acute testosterone deprivation reduces insulin sensitivity in men.
    Clinical endocrinology, 2012, Volume: 76, Issue:2

    In men with prostate cancer, androgen deprivation reduces insulin sensitivity; however, the relative roles played by testosterone and estradiol are unknown. To investigate the respective effects of these hormones on insulin sensitivity in men, we employed a model of experimental hypogonadism with or without hormone replacement.. Placebo-controlled, randomized trial.. Twenty-two healthy male volunteers, 18-55 years old.. Following screening, subjects received the gonadotrophin-releasing hormone antagonist acyline plus one of the following for 28 days: Group 1, placebo transdermal gel and placebo pills; Group 2, transdermal testosterone gel 10 g/day plus placebo pills; Group 3, transdermal testosterone gel 10 g/day plus the aromatase inhibitor anastrozole 1 mg/day to normalize testosterone while selectively reducing serum estradiol. Fasting insulin, glucose, adipokines and hormones were measured bi-weekly.. With acyline administration, serum testosterone was reduced by >90% in all subjects in Group 1. In these men, mean fasting insulin concentrations were significantly increased compared with baseline (P = 0·02) at 28 days, despite stable body weight and no changes in fasting glucose concentrations. Decreased insulin sensitivity was also apparent in the insulin sensitivity indices homeostasis model of insulin resistance (P = 0·03) and quantitative insulin sensitivity check index (P = 0·04). In contrast, in Groups 2 and 3, testosterone concentrations remained in the physiologic range, despite significant reduction in mean estradiol in Group 3. In these groups, no significant changes in insulin sensitivity were observed.. Acute testosterone withdrawal reduces insulin sensitivity in men independent of changes in body weight, whereas estradiol withdrawal has no effect. Testosterone appears to maintain insulin sensitivity in normal men.

    Topics: Adipokines; Adolescent; Adult; Chemokine CCL2; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Oligopeptides; Retinol-Binding Proteins, Plasma; Testosterone

2012

Other Studies

1 other study(ies) available for acyline and Insulin-Resistance

ArticleYear
Impact of acute biochemical castration on insulin sensitivity in healthy adult men.
    Endocrine research, 2010, Volume: 35, Issue:2

    Evidence supports an inverse relationship between serum testosterone (T) and insulin resistance in men. However, data with respect to causality are limited. The aim of this study was to explore the impact of acute biochemical castration on insulin sensitivity in healthy adult men.. Ten healthy, adult males (mean age 41.0 +/- 3.9 yr) were studied. Subjects were studied at baseline and after 2 and 4 weeks of biochemical castration. Outpatient hospital research setting. Body composition (dual-energy x-ray absorptiometry), energy expenditure (indirect calorimetry), abdominal and visceral adiposity (MRI), skeletal muscle intramyocellular lipid content ([IMCL] (1)H-MR spectroscopy), and insulin sensitivity (hyperinsulinemic-euglycemic clamp) were assessed before and after 2 and 4 weeks of biochemical castration induced by a GnRH antagonist (acyline 300 mug/kg subcutaneous every 10-14 days). Serum T, insulin and glucose levels, body composition, abdominal visceral fat, IMCL, and glucose disposal rate (M) were measured.. Acyline administration suppressed serum T to frankly hypogonadal levels in all subjects for the duration of the study (P <0.009). No significant changes in body composition, energy expenditure, or M were observed at either 2 or 4 weeks of castration. Acyline is an effective GnRH antagonist inducing acute castration in all subjects. ii) Four weeks of biochemical castration has no impact on insulin sensitivity in healthy men likely due to unchanged body composition variables. iii) Insulin resistance associated with chronic low T levels may be largely driven by decreased fat free mass, increased percent body fat, and/or other metabolic regulatory factors.

    Topics: Adult; Aged; Blood Glucose; Body Composition; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Insulin; Insulin Resistance; Intra-Abdominal Fat; Luteinizing Hormone; Male; Middle Aged; Muscle, Skeletal; Oligopeptides; Orchiectomy; Sex Hormone-Binding Globulin; Subcutaneous Fat; Testosterone; Young Adult

2010